These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16707032

  • 1. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML, Wiker C, Svensson TH.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM, Wiker C, Frånberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):891-903. PubMed ID: 19835668
    [Abstract] [Full Text] [Related]

  • 3. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
    Hertel P, Fagerquist MV, Svensson TH.
    Science; 1999 Oct 01; 286(5437):105-7. PubMed ID: 10506554
    [Abstract] [Full Text] [Related]

  • 4. Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat.
    Marcus MM, Jardemark KE, Wadenberg ML, Langlois X, Hertel P, Svensson TH.
    Int J Neuropsychopharmacol; 2005 Sep 01; 8(3):315-27. PubMed ID: 15857571
    [Abstract] [Full Text] [Related]

  • 5. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A, Wadenberg ML, Svensson TH.
    Biol Psychiatry; 2005 Aug 15; 58(4):337-43. PubMed ID: 16102547
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.
    Linnér L, Wiker C, Wadenberg ML, Schalling M, Svensson TH.
    Neuropsychopharmacology; 2002 Nov 15; 27(5):691-8. PubMed ID: 12431844
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level.
    Hertel P, Nomikos GG, Svensson TH.
    Eur J Pharmacol; 1999 Apr 29; 371(2-3):153-8. PubMed ID: 10357252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
    Marcus MM, Jardemark K, Malmerfelt A, Björkholm C, Svensson TH.
    Neuropsychopharmacology; 2010 Aug 29; 35(9):1952-61. PubMed ID: 20463659
    [Abstract] [Full Text] [Related]

  • 14. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
    Invernizzi RW, Garavaglia C, Samanin R.
    Neuropsychopharmacology; 2003 May 29; 28(5):872-9. PubMed ID: 12644843
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z, Huang M, Prus AJ, Dai J, Meltzer HY.
    Brain Res; 2007 Feb 23; 1134(1):70-8. PubMed ID: 17207474
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z, Ichikawa J, Dai J, Meltzer HY.
    Eur J Pharmacol; 2004 Jun 16; 493(1-3):75-83. PubMed ID: 15189766
    [Abstract] [Full Text] [Related]

  • 20. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M.
    Neuropsychopharmacology; 2000 Jun 16; 22(6):642-9. PubMed ID: 10788763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.